memantine has been researched along with Tauopathies in 4 studies
Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacological treatment of dementias aims to improve cognitive deficits, activities of daily living and behavioural and psychiatric symptoms." | 2.45 | [Antidementia drugs]. ( Müller-Spahn, F; Sollberger, D; Wollmer, MA, 2009) |
| "Early-onset dementia has a devastating impact on families and rids its victims of their most productive and rewarding years." | 2.44 | New approaches to the treatment of frontotemporal lobar degeneration. ( Miller, BL; Vossel, KA, 2008) |
| "Memantine was used at a clinically relevant dose (20 mg daily oral administration) from 4 (asymptomatic phase) to 10 (mild cognitive impairment phase) months of age." | 1.72 | Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia. ( Alves, S; Audrain, M; Billard, JM; Braudeau, J; Cartier, N; Dutar, P; Fol, R; Orefice, NS; Potier, B; Souchet, B; Tada, S, 2022) |
| "Background Tauopathies, including Alzheimer's disease (AD), are multifactorial diseases with strong phenotypic and genetic heterogeneity." | 1.51 | Pore-former enabled seeding of tau in rats: Alleviation by memantine and lithium chloride. ( Gasiorowska, A; Koss, DJ; Mietelska-Porowska, A; Niewiadomska, G; Palasz, E; Riedel, G, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Souchet, B | 1 |
| Audrain, M | 1 |
| Alves, S | 1 |
| Fol, R | 1 |
| Tada, S | 1 |
| Orefice, NS | 1 |
| Potier, B | 1 |
| Dutar, P | 1 |
| Billard, JM | 1 |
| Cartier, N | 1 |
| Braudeau, J | 1 |
| Mietelska-Porowska, A | 1 |
| Gasiorowska, A | 1 |
| Palasz, E | 1 |
| Koss, DJ | 1 |
| Riedel, G | 1 |
| Niewiadomska, G | 1 |
| Vossel, KA | 1 |
| Miller, BL | 1 |
| Müller-Spahn, F | 1 |
| Sollberger, D | 1 |
| Wollmer, MA | 1 |
2 reviews available for memantine and Tauopathies
| Article | Year |
|---|---|
New approaches to the treatment of frontotemporal lobar degeneration.
Topics: Animals; Dementia; DNA-Binding Proteins; Excitatory Amino Acid Antagonists; Humans; Intercellular Si | 2008 |
[Antidementia drugs].
Topics: Aged; Alzheimer Disease; Amyloidosis; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Dose- | 2009 |
2 other studies available for memantine and Tauopathies
| Article | Year |
|---|---|
Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia.
Topics: Alzheimer Disease; Animals; Humans; Memantine; Rats; Tauopathies | 2022 |
Pore-former enabled seeding of tau in rats: Alleviation by memantine and lithium chloride.
Topics: Alzheimer Disease; Animals; CA1 Region, Hippocampal; Disease Models, Animal; Lithium Chloride; Male; | 2019 |